Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine surgery. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.
Frequently asked questions
What sector does Medacta Group SA (MOVE) operate in?
Medacta Group SA belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Medacta Group SA (MOVE) current stock price?
As of the latest data, Medacta Group SA stock price is CHF 131.40, with a previous close of CHF 131.20. Medacta Group SA gained CHF 0.20 in the last trading session, representing a 0.15% increase.
What is Medacta Group SA (MOVE) current market capitalization?
Medacta Group SA market cap is approximately 2.62 billion.
What is Medacta Group SA (MOVE) Earnings Per Share (EPS)?
The trailing EPS is CHF 4.46, and the forward EPS is CHF 5.96.
What is Medacta Group SA (MOVE) Price-to-Earnings (P/E) ratio?
Medacta Group SA current P/E ratio is 29.46, with a forward P/E of 22.04.
Does Medacta Group SA (MOVE) pay dividends?
Yes. Medacta Group SA pays annual dividends with an annualized yield of 0.84% and an estimated annual payout of CHF 1.10 per share.
When is the next ex-dividend date for Medacta Group SA (MOVE)?
The next ex-dividend date is scheduled for May 07, 2027.
When is Medacta Group SA (MOVE) next earnings report?
Medacta Group SA is expected to release its next earnings report on June 30, 2026.
What is Medacta Group SA (MOVE) beta (volatility) score?
Medacta Group SA has a beta of 0.980, meaning its volatility is roughly in line with the market.
